The immune cell infiltration of CUPs and OPSCC was measured by evaluating the percentage of positive stained CD3- and CD8-positive tumor infiltrating lymphocytes (TILs) covering the tumor area in 5 high power fields. The gene discussed is CD8A; the disease is neoplasm.